#AI In Oncology market Top Manufacturers

[impactcare123]

Pharma Manufacturing Companies: Driving the Future of Healthcare Solutions

Pharmaceutical manufacturing companies are the backbone of modern healthcare, playing a crucial role in developing and delivering the medicines that keep us healthy. These companies go beyond simply producing drugs; they are at the forefront of healthcare innovation, developing advanced treatments for various diseases and conditions. In this blog, we’ll explore how top pharma manufacturing companies are driving the future of healthcare solutions and the impact they have on improving global health.

The Role of Pharma Manufacturing in Healthcare Innovation

Pharma manufacturing companies are responsible for the large-scale production of medicines, but their influence extends far beyond manufacturing. They are key drivers of innovation, continually researching and developing new drugs that tackle some of the world’s most pressing health issues. These companies are involved in:

Research and development (R&D): Discovering new treatments for conditions such as cancer, diabetes, and autoimmune disorders.

Cutting-edge technology: Using the latest advancements in biotechnology, genomics, and personalized medicine.

Global health improvement: Ensuring life-saving medicines are available to populations around the world.

Pharma Manufacturing Companies Leading Healthcare Solutions

Several pharma manufacturing companies are recognized for their leading role in driving future healthcare solutions. Here are a few industry giants making significant strides:

1. Pfizer

Pfizer is one of the world’s most recognizable pharmaceutical companies, renowned for its breakthroughs in vaccines and treatments for serious illnesses. Most recently, Pfizer made headlines for its development of the COVID-19 vaccine, which has had a transformative impact on global healthcare.

2. Roche

Roche is a global leader in biotechnology, focusing on creating personalized healthcare solutions. The company has made groundbreaking contributions in oncology and is known for its high-quality diagnostic tools that aid in early disease detection, helping to prevent illness before it escalates.

3. Novartis

Novartis is heavily invested in advancing gene therapies and personalized treatments. Their innovative approach to tackling diseases such as cancer and cardiovascular conditions has positioned them as a leader in both drug manufacturing and future healthcare technologies.

4. Johnson & Johnson

Johnson & Johnson, through its pharmaceutical division Janssen, focuses on developing innovative solutions for complex diseases. Their work in immunology, infectious diseases, and cancer treatment is helping shape the future of global healthcare.

5. Sanofi

Sanofi is a global healthcare company committed to developing treatments for a wide range of health challenges, including diabetes, cardiovascular diseases, and rare diseases. Their focus on R&D and sustainable healthcare solutions makes them a key player in the industry.

How Pharma Manufacturing Drives the Future of Healthcare

The future of healthcare lies in the hands of innovative pharma manufacturing companies that invest in research, technology, and partnerships. These companies are driving advances in healthcare through:

Biotechnology and gene therapy: Developing treatments that target diseases at the genetic level, offering hope for previously untreatable conditions.

Personalized medicine: Tailoring treatments to individual patients based on their genetic makeup, leading to more effective and precise therapies.

Artificial intelligence (AI): Using AI to streamline drug development, reduce costs, and accelerate the process of bringing new treatments to market.

Sustainable healthcare solutions: Incorporating eco-friendly production practices to minimize the environmental impact of drug manufacturing, ensuring that healthcare innovations are sustainable for the planet.

The Global Impact of Pharma Manufacturing Companies

The influence of pharma manufacturing companies extends globally, shaping the future of healthcare for millions of people. Their work leads to:

Improved patient care: Innovative treatments and personalized medicines improve outcomes and quality of life for patients with serious conditions.

Faster access to treatments: Cutting-edge manufacturing techniques allow new medicines to reach patients more quickly, especially during global health emergencies like pandemics.

Addressing global health disparities: Many companies are working to make essential medicines available in underserved regions, improving health equity worldwide.

Conclusion

Pharma manufacturing companies are not just producing medicines; they are driving the future of healthcare solutions through innovation, advanced technology, and a commitment to improving global health. Industry leaders like Pfizer, Roche, Novartis, Johnson & Johnson, and Sanofi are leading the way with groundbreaking therapies that are changing lives. As these companies continue to evolve, they will play an even greater role in shaping the healthcare solutions of tomorrow, offering hope and healing to millions worldwide.

[wellnessweb]

The Evolving Landscape of Cancer Biomarkers: Market Size Insights

The Cancer Biomarker Market size was estimated USD 11.1 billion in 2022 and is expected to reach USD 27.4 billion by 2030 at a CAGR of 12.0% during the forecast period of 2023-2030.The Cancer Biomarker Market is a dynamic landscape shaped by continuous advancements in biotechnology and precision medicine. As researchers delve deeper into the molecular signatures of cancer, novel biomarkers are identified, promising enhanced diagnostic accuracy and personalized treatment strategies. This burgeoning market is driven by the urgent need for non-invasive, early detection methods that can significantly improve patient outcomes. Innovations in genomic, proteomic, and metabolomic technologies are expanding the repertoire of biomarkers, offering hope for more targeted therapies and better prognostic assessments. The integration of AI and machine learning further accelerates biomarker discovery and validation processes, ushering in an era of tailored medicine where each patient's unique biological profile guides therapeutic decisions. With collaborations between pharmaceutical companies, diagnostic laboratories, and academic institutions intensifying, the Cancer Biomarker Market stands poised to revolutionize cancer care, marking a pivotal shift towards precision oncology.

Get Sample of This Report @ https://www.snsinsider.com/sample-request/4082

Market Scope & Overview

The market research report includes a comprehensive market analysis for the anticipated time period. The experts also looked into other industries where manufacturers could thrive in the future. The Cancer Biomarker Market research report looks thoroughly into the microeconomic and macroeconomic elements that drive market demand.

The research investigates the market's key driving and restraining forces, as well as upcoming trends and potential enhancements. Cancer Biomarker Market size, revenue, production, consumption, gross margin, pricing, and market-influencing factors are all included in this research report. The level of rivalry in the target market is developing as a result of competition in this business between large and small firms of all sizes.

Market Segmentation Analysis

By Type

Breast Cancer

Prostate Cancer

Colorectal Cancer

Cervical Cancer

Liver Cancer

Lung Cancer

Others

By Biomolecules

Genetic Biomarkers

Epigenetic Biomarkers

Metabolic Biomarkers

Proteomic Biomarkers

Others

By Profiling Technology

Omics Technologies

Imaging Technologies

Immunoassays

Cytogenetics-based Tests

By Application

Drug Discovery and Development

Diagnostics

Personalized Medicine

Others

By End-user

Hospitals

Academic and Cancer Research Institutes

Ambulatory Surgical Centres

Diagnostic Laboratories

COVID-19 Pandemic Impact Analysis

The study investigates the Cancer Biomarker industry's growth potential as well as the consequences of the ongoing COVID-19 situation. A full case study examination of important industry participants and their conduct throughout the epidemic is also included in the article.

Regional Outlook

Geographical Cancer Biomarker Market research is an excellent resource for stakeholders looking to expand into new regional markets. It helps readers understand the features and growth trends of distinct geographical markets.

Competitive Analysis

Extensive global market intelligence insight is included in the target market research. The research report looks extensively into the key market participants' company profiles, expansion goals, and business plans. Its statistical analysis of the global Cancer Biomarker Market includes CAGR, revenue, volume, market share, and other pertinent information.

Key Reasons to Purchase to Cancer Biomarker Market Report

Top rivals participated in mergers and acquisitions, collaborations, joint ventures, partnerships, product launches, and agreements, according to the report, to attain significant market expansion and global presence.

The target market report includes a firm profile, financial data, a SWOT analysis, and an in-depth analysis of industry competitors.

Conclusion

Cancer Biomarker Market research could assist industry participants in understanding their major competitors' competitive environment and business methods. This report's ability to assist market participants in gaining a competitive advantage and making educated business decisions would be beneficial.

Read Full Report @ https://www.snsinsider.com/reports/cancer-biomarker-market-4082

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Forensic Technology Industry

Functional Service Providers Industry

Genome Editing Industry

Genomics Services Industry

Health IT Security Industry

[organicmarketresearch1]

Global Active Pharmaceutical Ingredients (API) Market 2022-2032

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson and Johnson are the top 5 manufacturers of industry.

The Global Active Pharmaceutical Ingredients API Market Size was estimated at USD 67774.47 million in 2021 and is projected to reach USD 127217.78 million by 2028, exhibiting a CAGR of 6.60% during the forecast period.

This report provides a deep insight into the global Active Pharmaceutical Ingredients API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

Download Free Sample Report

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Active Pharmaceutical Ingredients API Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Active Pharmaceutical Ingredients API market in any manner.

Global Active Pharmaceutical Ingredients API Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

•Teva

•Mylan

•DSM

•Aurobindo Pharma

•Aspen

•Novartis

•BASF

•Pfizer

•Huahai Pharmaceutical

•Hisun Pharmaceutical

•Sun Pharmaceutical Industries

•Zhejiang Medicine

•Dr. Reddy’s Laboratories

•Zhejiang NHU

•Bayer

•NCPC

•AbbVie

•Shandong Xinhua Pharmaceutical

•Northeast Pharm

•Harbin Pharmaceutical

•LKPC

Market Segmentation (by Type)

•Synthetic APIs

•Biotech APIs

Market Segmentation (by Application)

•CNS

•Cardiovascular

•Genitourinary/Hormonal Drugs

•Respiratory

•Rheumatology

•Diabetes

•Oncology

•Others

Geographic Segmentation

• North America (USA, Canada, Mexico)

• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

• South America (Brazil, Argentina, Columbia, Rest of South America)

• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study

• Neutral perspective on the market performance

• Recent industry trends and developments

• Competitive landscape & strategies of key players

• Potential & niche segments and regions exhibiting promising growth covered

• Historical, current, and projected market size, in terms of value

• In-depth analysis of the Active Pharmaceutical Ingredients API Market

• Overview of the regional outlook of the Active Pharmaceutical Ingredients API Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

• This enables you to anticipate market changes to remain ahead of your competitors

• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

• Provision of market value (USD Billion) data for each segment and sub-segment

• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

• Provides insight into the market through Value Chain

• Market dynamics scenario, along with growth opportunities of the market in the years to come

• 6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Active Pharmaceutical Ingredients API Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market’s Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter’s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

About Us:

Organic Market Research Business Consulting is a fast-growing Market Research organization which is helping organizations to optimize their end-to-end research processes and increase their profit margins.

Organic Market Research facilitates clients with syndicate research reports and customized research reports on 10+ industries with global as well as regional coverage.

Mob : +91 9319642100

Noida One Tower Sec 62 Noida 201301

Sales : sales@organicmarketresearch.com

Website : https://www.organicmarketresearch.com

[researchupdates]

2021-2027 Flow Cytometry Market Trending Technologies, Remarkable Developments

Overview of Global Flow Cytometry Market:

The Market dynamics study of an influential Flow Cytometry report demonstrates the scope of the various commercial possibilities over the coming years and the positive revenue forecasts in the years ahead. Important industry trends, Market size, Market share estimates are analysed and mentioned in the industry analysis report. It also studies the key Markets and mentions the different regions i.e. the topographical spread of the business. The report gives helpful insights which assist while launching a new product. The large scale Flow Cytometry Market report helps business in knowing its Market share over various time periods, transportation, storage, and supply requirements of its products.

Under competitive Market share evaluation, it suggests that key players dominate the operations in the industry attributable to their strong geographical reach and huge production facilities. Global Flow Cytometry Market report serves to be an ideal solution for better understanding of the Market. It is helpful in finding out the size of the Market for specific products. These major players operating in this Market are in strong competition in terms of technology, innovation, product development, and product pricing. The Market study aids in making sales forecasts for its products and thereby, establishing harmonious adjustment between demand and supply of its products.

Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-flow-cytometry-market .

The Global Flow Cytometry Market is expected to USD 7.51 Billion by 2027 growing at a CAGR of 8.56% in the forecast period of 2020 to 2027.

The major key factors driving the growth of the Global Flow Cytometry Market are increasing public-private initiatives in the field of immunology and immuno-oncology research, Increasing incidence and prevalence of HIV/AIDS and cancer, availability of application-specific products, growing adoption of flow cytometry techniques in research and academia, increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software along with technological advancement.

Top Leading Key Manufacturers are: Bio-Rad Laboratories, Inc., Miltenyi Biotec Sysmex Partec GmbH, BIOMÉRIEUX, Mechatronics, Apogee Flow Systems Ltd., Stratedigm, Inc., Sony Biotechnology Inc., BD., Thermo Fisher Scientific Inc., Merck KGaA, ACEA BIO, Agilent Technologies, Luminex Corporation., Enzo Life Sciences, Inc., Beckman Coulter, Inc., Takara Bio Inc and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

In terms of the geographic analysis, North America dominates the flow cytometry market due to presence of supportive government reforms for the development of advanced technologies for molecular diagnostics, presence of a large number of clinical research labs and major pharmaceuticals in the U.S., while APAC is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to supportive government funding for the biotech industry development and presence of untapped opportunities, constantly improving healthcare infrastructure, rapid economic development, and rising patient awareness levels.

Access Complete Report Here: https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market .

[updatemarketanalysisreport]

Helpdesk Automation Market 2021-2026: Share, Size, Growth, Competitive Analysis with Key Players, Outlook, Revenue, and Forecast

According to the latest report by IMARC Group, titled “Helpdesk Automation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global helpdesk automation market size exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 23.6% during 2021-2026. Helpdesk automation is a customer support solution that is utilized to organize tickets related to issues varying in severity and priority. This management solution aids in resolving issues and queries of both customers and internal staff pertaining to a given product or service. Its utilization is associated with improving work efficiency by minimizing incomplete documentation, lost requests, delays in handling requests and poor communication to customers. These automated services are widely used for streamlining incoming communication, eliminating support costs, reducing redundant tasks, improving execution speed and increasing productivity. Apart from this, they enable automatic ticket allotment and closing services while timely initiating follow-ups with the costumers to offer superior customer experience.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.

Request Free Sample Report:  https://www.imarcgroup.com/helpdesk-automation-market/requestsample

Global Helpdesk Automation Market Trends:

The global market is driven by the growing adoption of artificial intelligence (AI) and machine learning (ML) across numerous industry verticals. These solutions, when integrated with helpdesk automation, provide chatbots and intelligent search recommendations to assist users. They also offer predictive analytics for incident management, demand planning, and workflow improvement, which has contributed to an increased demand for automated services. Helpdesk automation is also increasingly being integrated with information technology (IT) operations to improve the efficiency of the overall system. Significant growth in the IT industry, especially across developing economies, along with the growing adoption of cloud computing and mobile technologies on the global level, is also providing a boost to the market growth. Other factors, such as the increasing preference for e-retail websites, extensive research and development (R&D), and rapid urbanization, are further creating a positive outlook for the market.

Ask Customization and Browse Full Report with TOC & List of Figure: https://bit.ly/3b7BSH4

Key Market Segmentation:

Competitive Landscape with Key Player:

Atlassian Pty Ltd.

AXIOS SYSTEMS PLC

BMC Software, Inc.

Broadcom, Inc.

Ivanti, Inc.

HappyFox Inc

Resolve Systems

LLC ServiceNow, Inc.

Sunrise Software Limited

SunView Software

Vision Helpdesk.

Market Breakup by Product Type:

Incident Management Systems

Knowledge-Based Systems

Self-service Reset Password

Others

Market Breakup by Deployment:

Cloud Hosted

On-premise

Market Breakup by Organization Type:

Large Enterprises

Small and Medium Enterprises

Market Breakup by Vertical:

IT and Telecom

BFSI

Government

Education

Healthcare

Manufacturing

Automotive

Retail

Others

Market Breakup by Region:

North America

Europe

Asia Pacific

Latin America

The Middle East and Africa.

Key Highlights of the Report:

Market Performance (2015-2020)

Market Outlook (2021- 2026)

Porter’s Five Forces Analysis

Market Drivers and Success Factors

SWOT Analysis

Value Chain

Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Related Report:

Automotive Dyno Market: https://www.imarcgroup.com/automotive-dyno-market

Oncology Biosimilars Market: https://www.imarcgroup.com/oncology-biosimilars-market

Security Screening Systems Market: https://www.imarcgroup.com/security-screening-systems-market

Neuroendovascular Coil Market: https://www.imarcgroup.com/neuroendovascular-coil-market

Genset Battery Market: https://www.imarcgroup.com/genset-battery-market

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us: IMARC Group 30 N Gould St, Ste R Sheridan, WY (Wyoming) 82801 USA Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

[reportsjournal]

Serological Test Market Growth Trends and Forecasts 2021 - 2026

Serological Test Market Market Size – USD 24.55 billion in 2018, Market Growth - CAGR of 8.8%, Market Trends – Product launches and research for advanced Rapid Test

Reports and Data has added a new market research report titled Global Serological Test Market Forecast to 2028 to its ever-expanding database. The report spanning over 100 pages is a detailed overview of the market equipped with latest information about product types, application spectrum, revenue share, market growth, revenue growth, market share, market size, and top companies. Insightful data has been collected through extensive primary and secondary research and further validated by industry experts and professionals to offer key insights into statistical data of the market. The statistical data has been organized into tables, charts, diagrams, and other pictorial representations.

Furthermore, the report covers various important aspects of the industry such current and emerging trends, updated outlines, growth factors, restraints, growth prospects and opportunities, regulatory framework and government policies, macro and micro economic factors, and other factors that enable to draw projections for the estimated market growth in the forecast period.

Key companies operating in the global market and profiled in the report include:

Akers Biosciences, Inc., Alere Inc. (Abbott Laboratories), Becton, Dickinson and Company, Bio-rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc., OraSure Technologies, Inc., Quidel Corporation, and Roche Diagnostics.

The COVID-19 Impact:

The demand for the Serological Test will grow tremendously during the pandemic. New equipment will enhance and expand performance capabilities, which will build sales in hospitals, outpatient facilities. Overall, the pandemic crisis will lead to multiple changes, which will result in companies adopting different strategies to meet increasing demand. There will also be a substantial change in the product pipeline, and the overall supply chain as macroeconomic shifts take place. The use of AI and other technologies is another trend which is highlighted. Gains will be driven by expanded market products that help hospitals and large outpatient facilities improve the accuracy, quality, and efficiency of treatment. There is still a huge discrepancy between available Serological Tests and the need.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2283

For the purpose of this report, Reports and Data has segmented the Rapid Test market on the basis of product type, application type, end use, and region:

Product Type (Revenue, USD Million; 2016–2026)

Over-the-Counter (OTC) Rapid Test     Product

Professional Rapid Test Product

Application Type (Revenue, USD Million; 2016–2026)

Infectious Disease

Cardiology

Oncology

Pregnancy & Fertility

Toxicology

Glucose Monitoring

Others

End Use (Revenue, USD Million; 2016–2026)

Hospital & Clinic

Diagnostic Laboratory

Home Care

Others

Regional analysis covers:

·         North America (U.S., Canada, Mexico)

·         Europe (U.K., Italy, Germany, France, Rest of Europe)

·         Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

·         Latin America (Chile, Brazil, Argentina, Rest of Latin America)

·         Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Speak to Our Expert @ https://www.reportsanddata.com/speak-to-analyst-form/2283 Key Questions Answered in this Research Study:

What     is the global production, production value and consumption value?

Who     are the global key manufacturers of the market? How are their operating     situation?

What     are the types and applications of market?

What     is the market share value of each type and application?

What     are the upstream raw materials and manufacturing equipment?

What     is the manufacturing process?

Economic     impact on the market and development trends of market.

What     will be the market size and the growth rate be in 2026?

What     are the key factors driving the market?

What     are the key market trends impacting the growth of the market?

What     are the challenges to market growth?

What     are the market opportunities and threats faced by the vendors in the     market?

The report utilizes advanced analytical tools to research, gather, and analyze data. The in-depth research report has been formulated through extensive primary and secondary research and the data has been further validated and verified from industry experts, professionals, and research analysts. The report also offers strategic recommendations to key market players and novice players to overcome barriers and limitations and gain a robust footing in the market.

To know more about the report @ https://www.reportsanddata.com/report-detail/rapid-test-market

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.

[waaaiz]

Medical Imaging Market Research Report

Growth opportunities in the medical imaging market look promising over the next six years. This is mainly due to the increase in the prevalence of chronic disease, the rising geriatric population, and the escalation in the utilization of imaging devices in therapy.

Request for a FREE Sample Report on Medical Imaging Market

Medical Imaging Market Dynamics (including market size, share, trends, forecast, growth, forecast, and industry analysis)

Key Drivers

The surging incidences of chronic diseases across the nation is the major driver stimulating the growth of the medical imaging market. For example, the World Health Organization asserted that by the end of 2021, the extensiveness of these diseases is expected to boost by 60%. Moreover, the expanding aging population will further strengthen the medical imaging market size. In accordance with the WHO, the 60 years old population is likely to reach 2 billion because of the substantial rise in average life expectancy. The evolving technological innovations have positively impacted the healthcare sector, which is further contributing to market growth. For instance, technologies such as three-dimensional printing and Artificial Intelligence have boosted the present and future scope of market growth. Artificial intelligence produces the best image quality using ai alterations for CT scans and MRIs, which has enhanced radiology. Moreover, the expansion in the employment of these imaging devices in therapy coupled with an essential switch towards precision medicine has promoted the medical imaging industry.

Moreover, leading players like GE Healthcare, Shimadzu Corporation, Siemens Healthineers are engaged in the assistance of image therapy solutions, which will drive the market growth. For instance, Siemens Healthineers, in 2019, proffered a range of diagnostic solutions in the field of radiography and magnetic. Also, the company propagates more than 60% of its revenue from the imaging segment. For example, the company generated total revenue of 17,706 million, out of which 11,130 million was led by this segment, which exhibits the market's huge potential.

However, as per the medical imaging analysis, product retraction by prominent market players is predicted to obstruct the market growth. GE healthcare, in 2018, recalled Millennium MC, Millennium MG, and Millennium Myosight nuclear medicine systems, where they did not possess mechanical stopper and proper functioning of motion stopper.

End-Users Segment Drivers

Based on the end-users, hospitals are projected to expand at a CAGR over the forecast period. This is majorly attributed to the deliberate strategies by the government and regulatory development for the expansion and enlargement of the healthcare infrastructures. German Health Minister, in 2020 had stated US$ 3.53 billion for hospitals, which will bolster the market growth.

Medical Imaging Market’s leading Manufacturers:

·        PerkinElmer Inc.

·        Carestream

·        Varian Medical Systems

·        Toshiba Medical Systems Inc.

·        GE Healthcare

·        Siemens Healthineers

·        Aribex Corporation

·        Ziehm Imaging Inc.

·        Shimadzu Corporation

·        Koninklijke Philips N.V.

Medical Imaging Market Segmentation:

Segmentation by Modality:

·        Stationary

·        Portable

Segmentation by Procedure:

·        CT Scanners

·        MRI Scanners

·        Nuclear Medicine Imaging

·        Ultrasound

·        X-Rays

·        Others

Segmentation by Technology:

·        Direct Digital Radiology

·        Computed Radiology

Segmentation by Patient Age:

·        Adults

·        Paediatrics

Segmentation by Application:

·        Cardiology

·        Pelvic and Abdominal

·        Oncology

·        Mammography

·        Gynaecology

·        Neurology

·        Urology

·        Musculoskeletal

·        Dental

·        Others

Segmentation by End-Users:

·        Hospitals

·        Diagnostic and Imaging Centers

·        Specialty Clinics

·        Ambulatory Surgical Centers

·        Others

Segmentation by Region:

·        North America

o   United States of America

o   Canada

·        Asia Pacific

o   China

o   Japan

o   India

o   Rest of APAC

·        Europe

o   United Kingdom

o   Germany

o   France

o   Spain

o   Rest of Europe

·        RoW

o   Brazil

o   South Africa

o   Saudi Arabia

o   UAE

o   Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is a market research and consulting company that offers business insights and market research reports for large and small & medium enterprises. Our detailed reports help the clients to make strategic business policies and achieve sustainable growth in the particular market domain. The company's large team of seasoned analysts and industry experts with experience from different regions such as Asia-Pacific, Europe, North America, among others, provides a one-stop solution for the client. Our market research report has in-depth analysis, which includes refined forecasts, a bird's eye view of the competitive landscape, key factors influencing the market growth, and various other market insights to aid companies in making strategic decisions. Featured in the 'Top 20 Most Promising Market Research Consultants' list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to helping our clients to stay ahead of the curve.

Media Contact Company Name: GMI RESEARCH Contact Person: Sarah Nash Email: enquiry@gmiresearch.com Phone: Europe – +353 1 442 8820; US – +1 860 881 2270 Address: Dublin, Ireland Website: www.gmiresearch.com

[anjrawat]

Top Science and Healthcare Conferences in 2021

Apart from the preventive, remedial, and therapeutic service to the patients, the healthcare or the medical industry also plays a crucial role in the economic development of the country. The healthcare industry comprises many sub-segments such as medical devices, equipment, pharmaceuticals, hospital supplies, medical insurance, health care services and facilities and many others.

Today, technology has brought a new angle in the development of the Healthcare sector. The healthcare industry is growing rapidly due to technological innovations. Every day new researches, medical products and equipment, treatments methods, life-saving drugs and many other such products and services are making their way into the healthcare market. 

To get key updates on the recent advances, trends, research, the issues and challenges associated with them, every year a number of healthcare conferences are held worldwide. Apart from providing knowledge, these conferences provide a platform for bringing together the healthcare professional, organizations, institutions, companies, manufacturers and suppliers. 

With so many conferences held worldwide, we have sorted some of the leading conferences that you should watch out for in 2021. Here is the list of conferences - 

Dubai International Pharmaceuticals & Technologies Conference and Exhibition (DUPHAT)

09 - 11 March 2021

Venue - DICEC, Dubai, UAE

After gaining a significant outcome out of the past conferences, the Dubai International Pharmaceuticals & Technologies Conference and Exhibition (DUPHAT -2021) is supposed to be held on 09 - 11 March 2021. It will be the 25th edition of the DUPHAT. Over the years the DUPHAT has become a well-recognised brand among the healthcare professionals and pharmaceutical manufacturers worldwide. Last year DUPHAT had hosted over 33,000 professional and 750 brands and exhibiting companies from 75+ countries, which makes it one of the must-attend events in 2021 for the science and healthcare professional.

Pharma Forum 

22 - 24 March & 23 - 25 September

Venue - NYC, USA (Virtual & Face-to-face)

Pharma Forum is one of the world’s leading life sciences events that brings healthcare professionals, biotech, pharmaceutical, and medical device companies, together. The conference provides the opportunity to generate quality leads and collaboration, building relationships, sharing ideas, knowledge, innovation and many others.

Pharma Forum 2021 is supposed to be organized virtually (between March 22 - 24) and face to face (in Q3 2021 at New York City). The Pharma Forum has introduced innovative program features for the virtual event that includes -live and on-demand sessions & panel discussions, real-time q&as and polling, digital exhibit hall and enhanced ai-powered networking system. Pharma Forum through their website has conveyed that they will hold a face-to-face component of the event in Q3 of 2021 when it is safe to finally do. 

Arab Health Congress

 21 - 24 June 2021

World Trade Centre, Dubai, UAE

The Arab Health Congress is rescheduled to 21 - 24 June 2021. It is one of the largest healthcare events in the MENA region. The 2021 edition is expected to have the presence of 4,000+ exhibiting companies and 106,300+ professionals from 159 countries. Arab Health provides a wide range of benefits to healthcare professionals and exhibiting companies such as generating new business, increase in brand exposure, the launch of new products & services and opportunity to network with industry leaders & potential buyers.

BIO-Europe Spring 

22-25 March 2021

Venue - Delivered Digitally

The BIO-Europe Spring is one of the premier partnering conferences for the biotechnology industry. The annual conference attracts a large number of business leaders, including senior executives, investors, industry experts, and companies from biotech, pharma and finance sectors. 

BIO-Europe Spring 2019, had attracted over 1,700 attendees and 973 companies from 50 countries around the world. The BIO-Europe Spring 2021 is also expected to draw significant attendance. Amid the global health emergency due to coronavirus, the BIO-Europe Spring will be a fully digital event.

International Conference on Global Healthcare

22 - 23 February 2021

Venue- Vienna, Austria.

International Conference on Global Healthcare is a leading healthcare event that provides a platform to the healthcare professionals, physicians, researchers, practitioners, policymakers and representatives of consumer organisations. The Conference aims to provide the necessary information to the physicians about diagnosis, research findings and methodologies corresponding to Healthcare. 

Global Healthcare 2021 will be held on 22nd and 23rd of February, 2021 in Vienna. The event will cover the issues related to modernization, sustainability, impartiality, intellectual thinking and ambiguity, public health, healthcare management & administration, nanomedicine, nanotechnology, biotechnology, epidemiology and diseases control and many others.

ESMO CONGRESS 2021

17 - 21 September 2021

Venue - Paris, France.

ESMO is one of the leading scientific and educational meetings on the latest advances in oncology that is held yearly in Europe. It is attended by nearly 30’000 clinicians, researchers, oncology nurses, patient advocates, journalists and representatives of the pharmaceutical industry from all over the world. 

The 2021 annual ESMO congress will be held from 17 to 21 September at the Paris Expo Porte de Versailles, France. The conference ESMO Congress 2021 covers the vast range of activities and topics that includes the presentation of cutting-edge clinical data, latest discoveries in immunotherapy of cancer, therapeutics approvals, discussion, keynotes speeches and unrivalled networking opportunities for the attendees.

PharmScience Research & Development

22 - 24 February 2021

Venue - San Francisco, CA, USA 

The 3rd International Conference on PharmScience Research & Development will be held in San Francisco, USA during February 22-24, 2021. The Pharma R&D Conference provides the platform to communicate evolving scientific research, clinical development and medical education. 

Amid the Covid-19 pandemic, the Pharma R&D board and organizers have facilitated speakers to present their research via virtual presentations in the upcoming event. The conference will hold a series of sessions around drug discovery, drug delivery, clinical trials, pharmaceutical technology, pharmaceutical design, pharmacogenomics, personalized medicine and many others.

International Conference on Drug Delivery and Formulations

23 - 24 April 2021

Venue - Dubai, UAE

The 5th Edition of the International Conference on Drug Delivery and Formulations will be held on 23 & 24 April 2021 in Dubai, UAE. The 2021 edition of the event is themed around “Exploring New Research and Innovative Developments in Pharmaceutical.” 

The two-day event will be marked with keynote presentations, workshops and symposiums, oral presentations, exhibitions on new emerging technologies, special sessions and poster presentations. The scientific sessions will cover the topic on advances in drug delivery system, medical devices, drug discovery, nanotechnology & drug carrier system, pharmacovigilance, drug safety and business opportunities in drug delivery.

INTERPHEX 

19 – 21 October 2021

Venue - NYC, USA

INTERPHEX is one of the premier pharmaceutical, biotechnology, device development and manufacturing events in the United States of America. Since its inception in 1979, every year the event is attended by key healthcare professionals and leading suppliers around the world. The 2019 edition has featured over 600+ leading suppliers with around 89 new exhibitors and an overall increase in attendance form previous years.

The 2021 edition of the INTERPHEX will be held between 19 – 21 October 2021 at Javits Center, NYC. Throughout the 3 day exhibition, various technical conferences and seminars on the latest trends will take place.

World Conference on Pharmaceutical Science and Drug Manufacturing (WCPSDM)

 28 - 29 July 2021

Venue - Dubai, UAE

WCPSDM is one of the most renowned pharma conferences that provides a unique platform to the key stakeholders in the pharma industry to trade and distribute their phenomenal experiences, critical knowledge & innovations are being made in the pharmaceutical sciences. The 9th edition of  WCPSDM is supposed to be held on the 28th &  29th July 2021 in Dubai (UAE). The theme for the conference is “Challenges Faced in the Pharma Industry due to Outbreak of COVID-19”. The 2-day event will provide opportunities for the participants to explore and discuss the cutting-edge innovations in Pharmaceutical Science and Drug Manufacturing.

Due to the Covid-19, the situation worldwide is still out of control. All the event and conference organizers are carefully monitoring the current situation. Since most of the events included in the list are for the year 2021. The dates and venue for the exhibition are subject to change by the respective organiser and board members. Utmost care has been taken while preparing the list, we would advise referring to the official website before making any decision. 

[gojennybaker]

Global AI in Diagnostics Market Segmentation 2020 Competitive Landscape with Top Key Regions, Business Development Status, Market Opportunities and Key Drivers till 2028

Researching the AI in Diagnostics Market report provides comprehensive knowledge and valuable insight into current market prospects and emerging growth scenarios. The AI in Diagnostics Market Report focuses on market participants as well as new market entrants. In short, this report includes all the insights you need about global AI in Diagnostics markets such as cost / volume data, marketing strategies, and expert opinion.

The AI in Diagnostics market was valued at USD 412.8 million in 2020 and is expected to grow at a CAGR of 35.5% over the forecast period from 2020 to 2028.

Get a Sample Copy of This Report @ https://www.adroitmarketresearch.com/contacts/request-sample/1703

AI in Diagnostics Market Report provides detailed analysis of global market size, regional and national market size, segment growth, market share, competitive landscape, sales analysis, impact on domestic and global players, value chain optimization, trade rules, recent developments, opportunity analysis, strategic analysis of market growth, new product launches and technological innovation.

The report has analyzed several players in the market, some of which include: Aidoc, AliveCor, GE Healthcare, Imagen Technologies, Vuno Inc., IDx Technologies Inc., Siemens Healthcare GmbH, Neural Analytics, Riverain Technologies, Zebra Medical Vision, among other prominent players.

The prominent players in the market are categorized by price, quality, brand, product differentiation, and product portfolio. They focus on innovation in manufacturing technology to improve the efficiency and shelf life of products and services.

The AI in Diagnostics Market report contains many descriptions of market segmentation by product type and application, and provides a descriptive framework for trends and constraints across different segments and sub-segments.

Key segments of the global AI in Diagnostics market

Component Overview, 2018-2028 (USD Million)

Software

Hardware

Services

Application Overview, 2018-2028 (USD Million)

Cardiology

Oncology

Pathology

Radiology

Chest and Lung

Neurology

Others

Regional Overview, 2018-2028 (USD Million)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

Germany

United Kingdom

France

Spain

Rest of Europe

China

Japan

India

Rest of Asia Pacific

The report presents the market size with 2018 as the base year under review and the annual forecast to 2026 in terms of revenue (in millions of US dollars). Our analysts have implemented a combination of top-down and bottom-up approaches to market sizing, key regional markets, dynamics and trends for different types and applications.

Browse the complete report @ https://www.adroitmarketresearch.com/industry-reports/ai-in-diagnostics-market

Scope of Market

AI in Diagnostics Market Report helps you make informed business decisions with complete understanding and in-depth analysis of market segments.

It provides accurate analysis of the changing dynamics of competition and allows you to stay ahead of the competition.

Analysis of the many growth opportunities in the AI in Diagnostics industry for stakeholders and a detailed description of the competitive landscape for high-level players.

Key points related to market targeting AI in Diagnosticss such as product definition, application range, revenue statistics, supply and demand statistics.

Growth of the global AI in Diagnostics market in various regions such as North America, Europe, Asia Pacific, South America, the Middle East and Africa.

Competitive analysis of the main competitors in the market, as well as analysis of the latest trends and business strategies used by various companies.              

Market research also provides a comprehensive analysis of the global AI in Diagnostics market, including all industry stakeholders. Internal and external factors that influence the industry, both positively and negatively, have been carefully analyzed, which will provide a futuristic view of the market for decision makers.

Reasons why you should buy this report:

• Understand the present and future of the application AI in Diagnostics market in both developed and emerging markets.

• The report helps realign business strategies by highlighting business priorities by AI in Diagnosticss.

• The report sheds light on the segment that is expected to dominate the industry and the AI in Diagnostics market.

• Predicts regions waiting to climb.

• Latest developments in the AI in Diagnostics industry and insights from industry leaders as well as their market shares and methods.

• Save time on entry-level research as the report provides important insights into growth, size, leading players and industry segments.

• Save and cut time by conducting entry-level research showing growth, size, leading players and global market segments.

If You Have Any Query, Ask Our Experts @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1703

[soniyapande]

Measuring the Impact: Digital Pathology Market in Healthcare Industry

In current clinical practices, digital pathology technology has been instrumental. In the background of the latest Coronavirus outbreak, it has become more important resource in the research laboratory ecosystems and is gaining traction recently. Although it was initially created as a cost-effective pathological method to help pathologies achieve better efficiency, digital pathology is now reemerging as a key item for pathologies to present extended workflows in the global pandemic. Including emerging technologies as artificial intelligence (AI) and machine learning, the unprecedented advantages of digital pathology integration provide incredible diagnostic possibilities far beyond traditional cardiology, and radiation. The COVID-19 crisis immediately led to a rising demand for digital pathology, and the pathology industry’s fate may forever be changed.

Global Digital Pathology Market 2020 research report presents analysis of market size, share, and growth, trends, cost structure, statistical and comprehensive data of the global market. Research reports analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative and quantitative aspects of the Global Digital Pathology Market. The competition landscape, company overview, financials, recent developments and long-term investments related to the Global Digital Pathology Market are mentioned in this report.

Browse the complete Global Digital Pathology Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.databridgemarketresearch.com/covid-19-resources/covid-19-impact-on-digital-pathology-in-the-healthcare-industry

Global Digital Pathology Market Trends:

Digital pathology allows improved analysis, offers live zoom and multiple angle views, provides a dashboard view of data and annotations, and reduces errors by eliminating breakage and minimizing risk and misidentification. Apart from this, it is increasingly used by top clinical research organizations (CROs) and large biopharmaceutical manufacturers to streamline drug development processes in discovery, pre-clinical and clinical trials. This, along with the advancements in technology and software applications, such as the whole slide imaging technique, and LIS/LIMS interfacing, and high-speed networking, has fully integrated digital pathology into pathology workflows. Moreover, many leading companies are entering into a partnership to gain more profits. For instance, Huron Digital Pathology has collaborated with the University of Pittsburgh Medical Center (UPMC) on artificial intelligence-based image search. This helps in presenting a pathologist-centric approach to image retrieval at pathology informatics. Looking forward, the market value is projected to reach US$ 984.4 Million by 2025, registering a CAGR of 11.2 % during 2020-2025.

The worldwide Digital Pathology Market has been thoroughly examined and the findings are summarized in the published market report. Recent developments which can play a key role in the expansion of the Global Digital Pathology Market are described and discussed in the study. The scale of growth of the Global Digital Pathology Market has been provided during the forecast period 2020 to 2026 following comprehensive market analysis. Developing opportunities in a number of key areas have even been established and attempts to expand the market penetration they hold are discussed in the study. A summary of the industry has also been provided.

Impact and strategy

In pathology, we are now starting to see the beginnings of such irreversible shifts, as social distancing and quarantine have made it almost overnight that pathology works. Laboratory workers usually use validated methods to interpret patient biopsies attached to glass slides under a microscope over the last 150 years. This regular clinical practice has been completely interrupted along with appointments and tumor boards, and now the patients will have to wait longer to be treated and care for diseases such as cancer.

Digital Pathology, which records high-resolution tissue specimen images, was essential for the preservation of surgeries by pathologists during the pandemic. Such visual images can be viewed whenever possible and are easily exchanged in secondary opinions and views, or online, by overcoming the limitations of working with glass dispositive and microscopes.

Global Blood Culture Test Market – Industry Trends and Forecast to 2026

Global Blood Culture Test Market By Method (Conventional/Manual Methods, Automated Methods), By Product (Consumables, Instruments, Software and Services), By Technology (Culture-Based Technology, Molecular Technologies, Proteomics Technology), By Application (Bacteremia, Fungemia, Mycobacterial Detection), By End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Blood Culture Test Market:

Global blood culture test market is registering a substantial CAGR of 8.88% in the forecast period of 2019-2026. This rise in the market can be attributed to increasing amount of sepsis cases and high cost of treatment.

Global Blood Screening Market – Industry Trends and Forecast to 2027:

Global Blood Screening Market, By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay, Rapid Tests, Western Blot Assay, Next-Generation Sequencing, Others), Disease Type (Respiratory Diseases, Diabetes Mellitus, Oncology, Cholesterol, HIV/AIDS, Cold & Flu, Infectious Diseases, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027

Segmentations in report:

Digital Pathology Market Analysis by Product:

·        Scanner

·        Software

·        Communication System

·        Storage System

Get sample copy of Report Click Here: https://www.databridgemarketresearch.com/covid-19-resources/covid-19-impact-on-digital-pathology-in-the-healthcare-industry

[sapanas]

Artificial Intelligence in Healthcare Market – Driving Factors And Trends Of The Industry

This Market report “Global Healthcare Artificial Intelligence Market Research Report By 2023” provides detailed insight covering all important parameters including Development Trends, Challenges, Opportunities, Key Manufacturers and Competitive Analysis.

Healthcare Artificial Intelligence Market Synopsis

Market Research Future (MRFR) asserts that the global Artificial Intelligence in Healthcare market size is estimated to demonstrate 51.9% CAGR during the forecast period (2018-2023). Rising application of AI in the field of drug discovery is favoring the market growth to a large extent. Artificial intelligence (AI) is referred to as the engineering and science which is adopted to design intelligent machines like intelligent computer programs. It is a system which applies several human intelligence-based functions like learning, reasoning, and problem-solving skills on disciplines like computer science, biology, linguistics, mathematics, and engineering. Artificial intelligence is considered the next frontier for healthcare innovation. AI in healthcare is implemented for sorting both structured and unstructured data. Fields of healthcare like oncology, neurology, and cardiology are experiencing a growing application of AI.

Read more news on: https://www.medgadget.com/2019/09/global-healthcare-artificial-intelligence-ai-market-size-2019-industry-share-growth-technology-trends-competitive-landscape-top-key-players-and-regional-forecast-to-2023.html

Healthcare Artificial Intelligence Market Competitive Dashboard

The prominent players operating the Artificial Intelligence in Healthcare market are Koninklijke Philips N.V., IBM Watson Health, NVIDIA Corporation, CloudMedx Inc., Microsoft Corporation, Google, General Electric, Next IT Corp., Intel Corporation, DEEP GENOMICS, General Vision, and Stryker.

Healthcare Artificial Intelligence Market Potential and Pitfalls

Artificial Intelligence has developed several applications in the healthcare sector, such as delivery of health services, detection of diseases, drug discovery, and management of chronic diseases. It ensures effectiveness and efficiency which is likely to trigger its adoption rate in the coming years. AI has also strengthened its foothold in the healthcare research sector for delivering accurate results. This has further contributed to the growth of the market throughout the estimated period. The technology also helps to overcome the human resource crisis by providing increased productivity by automation of complicated tasks. With the increased application of AI in the field of the medical imaging industry, drug discovery, genomics, and precision medicine combined with the rising personalized treatments customized according to the requirements of an individual patient, the global Artificial Intelligence in Healthcare market is estimated to flourish.

The demand for artificial intelligence in order to perform data mining and trigger the speed of healthcare delivery services has increased. Moreover, the advent of novel and promising applications for diagnosing and monitoring the disease is predicted to contribute to the market growth throughout the assessment period. Advancements made in the data analytics will further propel the Artificial Intelligence in Healthcare market in the coming years. With a massive amount of data being generated every year in the healthcare sector coupled with the ever-increasing volume of big data has created the need to adapt AI so that data can be managed effectively. The AI research team of Google has recently launched its Google Deepmind Health project for data mining of medical records in order to offer better and faster services.

On the contrary, strict mandates regulating AI and high cost associated with its implementation are anticipated to slowdown the market growth throughout the assessment period. Moreover, the reluctance among the healthcare professionals and an imprecise regulatory scenario in order to adopt such technologies are presumed to hinder the market growth in the coming years.

Global Artificial Intelligence in Healthcare Market: Segmental Analysis

The global Artificial Intelligence in Healthcare Market Report has been segmented on the basis of component, application, technology, and end-users.

By mode of component, the healthcare AI market has been segmented into software, hardware, and services.

By mode of application, the healthcare AI market has been segmented into virtual nursing assistant, robot-assisted surgery, clinical trial, dosage error reduction, automated image diagnosis, and preliminary diagnosis. Among these, the robot-assisted surgery is predicted to occupy a significant share owing to the high flexibility and precision ensured by robot-assisted surgeries during performing complicated procedures.

By mode of technology, the healthcare AI market has been segmented into querying method, machine learning, and natural language processing. Among these, the machine-learning segment is predicted to experience the highest CAGR owing to the ability to handle multiple dimensional data while enabling a reduction in the process time cycle.

By mode of end-users, the global Artificial Intelligence in Healthcare market has been segmented into pharmaceutical & biotechnology companies, hospital & diagnostic centers, and academic & research laboratories. Among these, the hospitals & diagnostic centers occupy the largest market share owing to the extensive application of AI in diagnostic imaging and robotic surgeries.

Healthcare Artificial Intelligence Market Regional Insights

Geographically, the Artificial Intelligence in Healthcare market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Among all the regions, the American region is estimated to dominate the AI in the healthcare market and is likely to retain its dominance in the coming years. The growth in this region is credited to the growth witnessed in the biotechnology sector. Moreover, the augmenting cases of robotics surgeries coupled with the presence of a well-developed healthcare sector are contributing to the growth of the market in this region.

The European region has secured the second position and is estimated to garner USD 3453.4 million during the appraisal period. The factors catalyzing the proliferation of the market are the extensive R&D made for healthcare AI combined with the rising funding.

Meanwhile, the Asia Pacific region is likely to register 52.4% CAGR in the coming years owing to the increased therapeutic demand for chronic diseases. Also, the fast-developing healthcare sector is influencing the market growth to a large extent.

Healthcare Artificial Intelligence Industry Updates

February 21, 2019: A team of scientists from the University of California and the University of Surrey has together used AI network in order to identify and scrutinize the symptoms in patients suffering from cancer. The new study elaborates how researchers have used network analysis in order to examine the relationship and structure between 38 common symptoms reported by the cancer patients receiving chemotherapy.

Obtain Premium Research Report Details considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/healthcare-artificial-intelligence-market-5681

[linhgd9]

Worldwide Staff Chair Market In-Depth Analysed Research Report 2021

GLOBAL Staff Chair MARKET 2020 OVERVIEW, POTENTIAL GROWTH, GLOBAL COVID-19 SURVEY, EXTENSIVE REPORT, SHARE, KEY FINDINGS, COMPANY PROFILES, COMPREHENSIVE REVIEW, INNOVATION, EMERGING TECHNOLOGIES, TRENDS, AND FORECAST

Global Staff Chair market examines changing market conditions and keeps you ahead of rivals. It comprises incredibly useful information for new and growing businesses to categorize themselves on the market. Staff Chair Market report also encompasses the world’s regions and states, which demonstrate a status for regional development. The research study will define an important portion of the marketplace and markets with respect to output, profits, product use, and gross margin.

Top listed players for global Staff Chair Market are: Lifeform Furniture Manufacturing, Elite Office Furniture, CHUENG SHINE, Izzy+, PSI Seating, ITOKI, AIS, Foshan Long Ma Office Furniture

Description of this report:

The report contains the expected CAGR calculated for the Staff Chair market based on past and present records of the Staff Chair market. The report provides a comprehensive analysis of the Staff Chair market and the key developments in the market. The market research and analysis cover historical and projected market data, production, product information, price trends, and geography-leading company shares of Staff Chair.

First, the study segments the market size by volume and value, depending on product form and regions.

Secondly, this report includes the present status and prospects for the future of the Staff Chair global market.

You Can Browse The Complete Staff Chair Market Report @ https://www.marketresearchstore.com/market-insights/staff-chair-market-807553

Staff Chair Market 2021 Global Industry Research Report is a comprehensive as well as in-depth study on the production, development, distribution, patterns, and evaluation of the market. Moreover, this study also includes market size, the profit share of each portion and its thread-segments, as well as estimated statistics. The research study provides important information on the business position of producers of Staff Chair and provides significant advice and recommendations to individuals and organizations involved in the sector.

Product Specification as per Types: Leather, Cloth, Plastic

Application By End User: Enterprise, School, Government

Market by Region: Middle East and Africa(GCC Countries, South Africa, Rest of Middle East & Africa), North America(U.S., Canada, Rest of North America), Europe(UK, Germany, France, Italy, Spain, Rest of Europe), Latin America(Brazil, Argentina, Rest of Latin America), Asia Pacific(Japan, India, China, Southeast Asia, Rest of Asia Pacific)

INVESTOR IMPORTANT BENEFITS-

•    The analysis on Staff Chair provides detailed qualitative perspectives into the future and target markets or regions with attractive development. •    The report presents a thorough analysis of existing and emerging market developments and prospects within the universal trade for Staff Chair. •    This provides a detailed overview of the factors that contribute to and constrain market development. •    By observing main product placement and tracking within the business environment of the top rivals, A thorough competition analysis is done. •    The report provides comprehensive qualitative and quantitative reviews of current trends and prospective forecasts that will better determine the market opportunities that exist. •    The study also focuses on Global Staff Chair market-leading global industry leaders providing information such as business profiles, product description and specification, size, capability, expense, supply, sales, and contact information. •    Research of the existing raw resources and materials and the downstream trade is also performed. •    Through tables and figures helping to analyze the gross oncology medicines sector globally, this report offers important information on the state of the industry and is a trustworthy source of guidance and advice for businesses and consumer-interested individuals. •    Trends in business growth and marketing channels for global Staff Chair are studied. Finally, the feasibility of new investment projects is evaluated and the all-inclusive conclusions of the investigation are offered.

Get Exclusive Sample Copy of Research Report @ https://www.marketresearchstore.com/sample/staff-chair-market-807553

RESEARCH GOALS:

•    To consider the market structure of Staff Chair through the analysis of its various sub-segments. •    Focuses on the leading global producers of Staff Chair, to identify, explain and evaluate turnover, pricing, profit margins, competitive market environment, SWOT analysis and zoning changes in the coming years. •    To evaluate the Staff Chair about individual growth rates, future prospects and their relation to the overall market. •    Sharing specific information on important factors affecting market growth i.e. growth potential, prospects, drivers, market-specific obstacles and risks. •    To forecast submarket use of Staff Chair in terms of major regions along with their corresponding target countries. •    Analyze industry trends such as new product releases, extensions, negotiations, and business acquisitions. •    The key players are to be strategically characterized and their growth plans evaluated in detail.

Also, Read Top Selling Reports:

Communication Router

Intrusion Prevention System

For more information feel free to ask: sales@marketresearchstore.com

from NeighborWebSJ https://ift.tt/3jD7h9h via IFTTT

from WordPress https://ift.tt/3AmqNgo via IFTTT

[alex121world]

Magnetic Resonance Imaging Market Trend Shows A Rapid Growth By 2026 | Trendsmarketresearch 2018 - 2025

This market research report includes a detailed segmentation of the global magnetic resonance imaging market by product type (closed MRI systems and open  MRI systems), by field (low field MRI systems, high field MRI systems, and very high MRI systems), by applications (cardiology, neurology, oncology, gastroenterology, musculoskeletal, and others), by end-users (hospitals, ambulatory care, diagnostic centers, and others), and by regions (North America, Europe, APAC, and RoW).

This Press Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.trendsmarketresearch.com/report/sample/11558

Research Overview

Infoholic Research predicts that the global magnetic resonance imaging market will grow at a CAGR of 7.5% during the forecast period. Medical imaging is growing substantially as it is the primary tool for diagnosing a wide range of diseases. The development of computer-aided diagnostics that have integrated in radiology services has enabled to diagnose and produce high quality images and expand the reach and improving the quality of diagnosis. Today there are many challenges faced by radiologists and the most common diagnostic issue is the collection of data about patients in larger volume that is complex. However, EMR and EHR are used to smoothen the process flow, whereas AI is leveraging the cloud-based features with imaging softwares and solutions that will solve many problems of radiologists.

The market is witnessing drastic changes in technology that has led to high adoption of MRI systems across various chronic diseases examination. Further, the advancements in Artificial Intelligence (AI) is replacing human analysis. Increase incidence of chronic diseases, rise in geriatric population, growing awareness about early benefits of diagnosis, and introduction of advanced MRI systems with better image quality is driving the market. The market is fueled by innovation and new technological techniques & procedures. The increase in demand for more advanced & customized diagnosis and treatment with availability of vast healthcare services globally have pushed the market to produce safe, efficient, and cost-effective products in the market. The advancement in technology has shifted most of the developed economies towards 3T product segments for high quality images. The last two decades have witnessed an unparalleled growth in advanced and innovative technologies, which resulted in the development of state-of-the-art medical device industry.

Segmentation by Product Type:

Closed MRI Systems

Open MRI Systems

The closed MRI systems are the most widely and commonly used equipment in hospitals and diagnostics centers across the globe. These are long and capsule like MRI scans that give high quality images. They share the maximum revenue in the global MRI market and is expected to grow steadily in the market.

Segmentation by Applications:

Cardiology

Neurology

Oncology

Gastroenterology

Musculoskeletal

Others

In 2018, the cardiology segment accounted for the maximum share with increased use of angioplasty, stenting, and pacemakers’ procedures.

Segmentation by End-users:

Hospitals

Ambulatory Care

Diagnostic Centers

Others

In 2018, hospitals gained the highest share in the global magnetic resonance imaging market with large volumes of diagnostics and treatments globally.

Segmentation by Regions:

North America

Europe

APAC

RoW

According to Infoholic Research analysis, North America accounted for the largest share of the global magnetic resonance imaging market in 2018. In North America, the US and Canada are the leading countries. Europe is the second leading region. The market in Europe was largely driven due to advances in medical imaging technologies. Factors such as increase in the prevalence of diseases, continuous adoption of advanced technologies, and increasing aging population are driving the market. The leading countries are Germany, France, UK, and Italy to the market. This region dominates the overall presence of ultrasound devices and has the most diversified MRI systems available in the market. It has the highest percentage of elderly population with many individuals with chronic diseases such as CVD, diabetes, obesity, high blood pressure, and other neurology related disorders.

The APAC region is expected to grow faster due to increase in sales of new MRI systems in the coming years. This is due to high demand for imaging equipment due to rapid increase in the number of hospitals and diagnostic laboratories, especially in countries such as India and China.

Competitive Analysis The competition in the magnetic resonance imaging industry is intense and has immense potential opportunity for vendors (especially technology service providers) to integrate with medical devices for new product launches. The market in the developed countries is witnessing increased adoption of MRI systems for high-quality imaging, screening, and diagnosing due to improved access and encouragement from the government & other healthcare institutions. The market is highly dynamic with the presence of few big players accounting for more than 65% share in the overall market. Pureplay vendors such as Aspect Imaging has introduced the world’s first complete and most effective permanent magnet simultaneous PET/MRI solution for preclinical research. The company has wide range of applications with top quality multimodality imaging tools. The vendors are focusing on developing strategic alliances with companies that manufacture medical imaging systems to leverage their products and widen their customer base by delivering for unmet medical needs.

Key Vendors:

Siemens Healthineers

GE Healthcare

Fujifilm Holdings Corp.

Philips Healthcare

Canon Medical Systems

Key Competitive Facts:

The market is highly competitive with all the players competing to gain the market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.

The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.

Responding to competitive pricing pressures specific to each of our geographic markets

Protection of proprietary technology for products and manufacturing processes

Get COVID-19 Report Analysis understand the COVID19 impact and be smart in redefining business strategies@ https://www.trendsmarketresearch.com/report/covid-19-analysis/11558

Benefits The report provides complete details about the usage and adoption rate of magnetic resonance imaging systems. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data.

Detailed market analysis focusing on the growth of the magnetic resonance imaging

Factors influencing the growth of the magnetic resonance imaging

In-depth competitive analysis of dominant and pureplay vendors.

Prediction analysis of the magnetic resonance imaging industry in both developed and developing regions.

Key insights related to major segments of the magnetic resonance imaging

The latest market trend analysis impacting the buying behavior of the consumers.

[acuitilabslondon]

Best SAP Innovations Witnessed by various industries in 2019, What has 2020 got for you?

SAP is the new age technology and calling it as one of the most intelligent, yet simplified technology of the last decade couldn’t be wrong! From digitally transforming a lot of businesses to giving them an entirely new face for the customers, SAP has truly been a technology that has changed the business game for many in the past years.

As 2020 is already here, many businesses involved in big data spaces are eager to understand and grab upon the next set of SAP Innovations and latest technology trends that this new year has got in for them. Measures to achieve organisation’s bigger goals, transforming and redefining business strategies to offer significantly better customer experience, and focusing on the latest trends to remain ahead of the competitors are a few points that every business promises to follow while at the starting of a new year. 2020 is no different when it comes to enhancing the business and following the latest tech trends.

Another thing that remains static, is the focus on innovation. These innovations could be in the form of anything like launching a new product, or a solution, or it could also be a service. The businesses that will keep innovation as their primary focus in 2020, will flourish and here is when SAP’s latest tech trends are going to help you!

Role of SAP Innovations to fulfill Customer Demands

Customers are evolving over the period of time and so are their expectations. This has somehow created a virtual world of outgrown competition with which every business is dealing in reality. If you are looking for a solution to solve the most complex business problems and want to bring your company’s vision to life, SAP’s innovative solutions can help you. Many businesses are already taking advantage of SAP’s offerings and had achieved the greatest goals through unique and leading-edge software innovations. In 2020, it’s your turn to collaborate with SAP to provide a unique experience to your customers right from discovery to delivery.

Industries that have been benefited with SAP innovations in 2019:

SAP’s latest tech trends and innovations had already helped many organizations in bringing their vision to life and transformed the way they use to deal with their business problems.

Get Benefited from SAP’s experts who have built over 4000 innovative solutions for more than 1500 clients across the range industries including:

1. Health Care

The American Society of Clinical Oncology is shaping the future of cancer care by providing individualised solution. With the help of big data stored in the cloud, people can easily access it and use it to create personalised evidence-based treatment plans which will further result in better patient care.

2. Agriculture

In agriculture, ‘Stara’ – which is a farm equipment manufacturer is reimagining its ecosystem and fundamentally changing its business models with the exceptional solutions by SAP that are helping to digitally connect ‘the internet of things across people, plants and machines. These innovations are helping the company realise its goals in a better way.

3. Transportation

Trenitalia, a high-speed rail company is using a tailored, dynamic magnets management SAP solution that harnesses the internet of things to analyse censored data from trains in real-time. Now customers enjoy better service and the company is saving 8-10% cost annually

4. Retail

A retailer company, Tata CLiQ launched the first of its kind ‘phygital’ marketplace with SAP Hybris Solution to combine the Physical and Digital world. Now, the customers are enjoying seamless omnichannel shopping experience that is personalized so that they feel special every time they visit or buy from here.

5. Entertainment:

Cirque du Soleil, has revolutionized its fan experience by investing in an interactive mobile app. This app is creating a more impressive fan experience.

Make your innovations real with SAP innovative solutions. Now, it is your turn to best utilize these and let your business bloom in 2020. Bring your concepts to life with high value, individualised solutions built by SAP experts.

SAP Tech Trends and Predictions for 2020

1. Big Data

Big Data is the huge collaborated data that we deal with almost every day in our lives. This data keeps flowing and moving from one computer to another computer or devices like mobile or machine sensors. With the use of the right big data tools, your organization can easily manage, store, and analyse this data and get valuable insights that were earlier impossible to imagine.

Big Data can play a vital role in transforming the decision-making ability of you your business with the help of technologies like in-memory data management, analytics, artificial intelligence (AI), and machine learning. Big data solutions for SAP can easily manage your various data landscape – across data warehouses, data lakes, and databases – with perfect to use on-premise and Big Data cloud solutions.

With the use of SAP HANA, you can easily transform the way you deal with the business challenges and get the responsiveness and processing power to make the most out of new opportunities.

2. Machine Learning

Machine learning is a smart technology that educates the computers to perform tasks in a desired way through learning from data – instead of getting it done to explicit programming.

Through the collaboration done with top universities in the world, SAP is all set to explore the more futuristic choices of machine learning and expand the technology for businesses. This collaboration will help SAP in focusing on a lot of different machine learning research topics and work on resolving open AI challenges in various industries.

3. Cloud Computing

Cloud computing can be simply defined as the process of delivering the applications, platforms, data storage, operating systems, and other computing resources over the Internet instead of doing it over on-premise infrastructure.

Businesses like yours can be benefited by choosing the cloud solution as by doing so you don’t need to make direct investments in hardware or IT staff, but get a subscription to the computing resource based on your requirement and pay the amount only for what you use.

These are three main SAP innovations cloud deployment options from which you can choose the best fit for your business requirement – public, private, or hybrid cloud. SAP promises to provide the most secure cloud platform that is maintained with the highest quality standards so that your data is safest.

4. The Internet of Things

The Internet of Things can be defined as a network of physical objects like vehicles, objects, machines, home appliances etc. that use sensors & APIs to connect and exchange data over the Internet.

Get the most out of the Internet of Things and SAP in 2020 for your business with high-tech IoT applications, software, and services.

5. Blockchain

Unlock the potential to revolutionize the way your business currently operates with Blockchain technology. Blockchain is based on distributed ledger technology, which securely records information across a peer-to-peer network. Join SAP Blockchain group and stay ahead of the competition. Easy communicating and networking with peers, staying updated with the latest industry trends and knowledge from speakers and SAP experts are a few best advantages that any business will be able to take while using Blockchain.

6. Digital Transformation

A fundamental rethinking of customer experience, business models, and operations is what digital transformation is all about. Any business that chooses digital transformation automatically chooses new ways to deliver value to the customers, generate better revenue, and improve efficiency.

Now or later, every business will eventually have to opt for digital transformation. A few businesses are under pressure to go for digital transformation and built a strong clientele, while there are others that are looking forward to it and moving ahead with slowly. Are you among those businesses that need to be transformed digitally in 2020?

Customer Satisfaction remains the primary goal for businesses in 2020 too –

Just like 2019, 2020 will also be a year for businesses that will keep their primary focus on Customer Satisfaction. The market will be dominated by the businesses that will understand the customer requirements better than ever before and offer them exactly what they need, even before they know they need that.

Innovation and success of your business success go hand in hand and thus SAP innovations are going to play a vital role in defining the success rate of business growth in 2020.

[holytheoristtastemaker]

Frost & Sullivan is offering insight on what to expect in the healthcare industry post-pandemic including the acceleration of virtual clinical trials and increased use of AI.

There is no doubt that the future of healthcare lies in digital technologies. The next two decades will be the age of the bioeconomy, which will have a significant impact on the economy, society and human lives. The convergence of AI, analytics and computations will allow healthcare to become a more measurement-driven business and fuel innovations that will have a far-reaching impact on how businesses will run in the long term.

Realizing a digital future in healthcare after COVID-19 pandemic

As the healthcare industry strengthens its scientific arsenal, it also needs to recognize the new normal and implement emerging, sustainable business models. Frost & Sullivan published its predictions for 2020 in December 2019, and while some still hold, we must acknowledge the significant impact and changes driven by the COVID-19 pandemic. This new vision for a digital future in healthcare for 2020 and beyond will not just focus on measuring segment resilience, identifying business continuity plans and highlighting the promise of digital tech -- it will also explore the implementation framework and immediate opportunities for a smoother transition.

A lost year for healthcare

Before the true magnitude of the pandemic came to fore, 2020 was expected to be the year when the total healthcare market would cross the $2 trillion mark and witness comfortable growth of 5.3%. However, as the situation unfolded, it became clear that growth would not cross 3.1% even in the most optimistic scenarios. While some segments like pharma and diagnostics will remain more resilient and continue to grow at 4% to 5%, medical imaging and medical devices will take the hardest hit and will experience best-case revenue declines of 31% and 2%, respectively.

The healthcare IT segment is expected to grow at almost 8%, due to the steadfast growth in the telehealth market. But despite some technical gains, there's still expected to be a loss of $45 billion in revenue and as much as $92 billion if things do not start recovering by the end of the second quarter in 2021.

By the middle of 2021, the healthcare industry will get back on its original growth trajectory; however, this will depend on new opportunities, which we explore below.

Prediction 1: Virtual clinical trials will make up 40% to 45% of all trials

By the end of 2020, 33% of global clinical trials will be disrupted, putting $3 billion in new product revenues at risk. Contract research organizations and pharma sponsors will increasingly lean on clinical trial IT offerings aiming for hybridization of patient recruitment, retention and monitoring to circumnavigate the most immediate challenges associated with social distancing. Consequently, we anticipate the mHealth and wearables-driven IT market will reach $560 million without the cost of the devices. Although virtual trials reduced the total trial costs by 15% to 20%, real-world applications were limited to observational trials. However, the initiation of Janssen's first-ever fully virtual interventional trial (NCT04252287) has set the right tone in 2020. The adoption momentum will vary based on product groups, particularly complex products like biologics.

Organic factors such as concerted efforts from logistic companies like Marken, clinical research  providers like Science 37, contract research organizations like PRA Health and inorganic factors like the COVID-19 pandemic will also accelerate the transition from traditional to hybrid to fully virtual designs across product groups and geographies in the next five years.

Prediction 2: Alternate testing sites to change point-of-care (POC) testing service paradigm

If there is one way to contain the spread of any infectious disease, it is testing. Bold measures have been taken during the pandemic including free, drive-through and walk-through testing and a large enabler has been (POC) testing. According to our research, countries around the globe are expected to maintain COVID-19 test volumes exceeding 500,000 subjects per day throughout the year for population surveillance and will generate $1.98 billion in revenue.

While the rise in testing is inevitable, the looming change is the emergence of alternate testing sites such as pharmacies or ports of entry. Although flu testing at pharmacies has been commonplace, 2020 is ushering in an era where pharmacies offer an unprecedented level of convenience to patients. They will move from screening to clinical lab-grade diagnostic and on-the-spot teleconsultation, followed by medication dispensation and reimbursement processing, all in a single patient visit, which can span just a couple of hours. This model will scale new heights in the coming years with test developers like Sherlock and Mammoth Biosciences close to the goal of achieving around $15 per test with a turnaround time of five to 15 minutes and sensitivity of 90% to 99%; SAP and Oracle offering high-grade data integration and connectivity; and pharmacies like CVS with 20,000 locations across the U.S.

The new model is sure to find traction with immediate advantages like triaging high-risk patients and reducing the lab burden, mid-term advantages like patient convenience and long-term advantages like rapid clinical trial recruitment.

Prediction 3: Ventilator surplus and remote monitoring to redefine non-hospital and home critical care model

Several healthcare and non-healthcare companies like Philips, Medtronic, Getinge, General Motors, Ford, Dyson and even Fitbit have responded commendably to the COVID-19-induced ventilator shortage. While this quick response and supply are critical, this will leave an uneven surplus once the pandemic is behind us. Frost & Sullivan's current estimates for 2020 indicate that the U.S. will end up with a surplus of approximately 100,000 ventilators. Germany and the UK might just meet their demand, but France, Italy and Spain collectively will face a deficit of almost 30,000 to 50,000 ventilators, which might be purchased through the rest of 2020.

This is likely to reset the critical care medicine paradigms, especially as manufacturers stare at sale losses for subsequent years until demand picks up again. Though a fraction of the surplus will end up in federal stockpiles, a large portion will be absorbed by hospitals. Most notably, the portable designs will end up in homes, redefining non-hospital care models. Already, 95% of home medical equipment providers in the U.S. are reporting challenges in securing new equipment from manufacturers. The ongoing shift toward care delivery in homes, along with healthcare workforce shortages and associated fatigue of the existing personnel, will drive this trend further.

Another positive change expected from this surplus is the advancements in remote monitoring technologies including ResMed's cloud-based Airview platform. We expect the ventilator market to see a jump of 400% in 2020 and reach $4 billion in revenue in Europe and the U.S. combined. However, sustainability of this growth will call for a review of creative leasing models, embedding remote monitoring and control in newer designs and utilizing analytics  to usher in a new era of growth in an otherwise mature and sluggish segment.

Prediction 4: Informatics and AI address workflow automation and operational analytics

Globally, the first and second quarter were quieter for the radiology department. According to Frost & Sullivan estimates, there has been a 50% to 70% reduction in footfall for elective procedures for oncology, cardiology, neurology and general radiology, creating a revenue deficit of $25 billion to $30 billion in imaging services alone. Nevertheless, with the early signs of a return to normalcy, the pent-up demand for elective procedures will grow in the remaining quarters.

At current trends, radiology, which is serving at 25% to 30% capacity, is expected to scale up to 65% to 75% by Q4 in 2020. This much needed upward swing would have ordinarily been challenged by current aging equipment fleet and technology obsolescence in the installed bases, but the new infrastructure investments made in teleradiology and AI as part of COVID-19 stimulus packages will bring the anticipated growth to fruition. This next-generation imaging equipment fleet will not only address historical concerns about the total cost of ownership and productivity gains, but it will also boost workflow efficiency by 40% to 50%.

As a result, it's predicted that teleradiology and AI will bring 2x growth in comparison to Q3 and Q4 of 2019 and drive $6 billion to $7 billion of imaging business in the second half of 2020.

Prediction 5: Virtual consultations by HCPs will witness greater than 100% growth in U.S.

As Europe and the U.S. crossed unfortunate milestones with the number of patients affected by COVID-19, the telehealth industry received a boost. Frost & Sullivan forecasts that revenue from virtual visits will display 124.3% growth in 2020 in the U.S. alone, which is the largest telehealth market and the biggest COVID-19 hotspot. However, this growth is pressure testing the existing network infrastructures and models -- the wait time for a virtual visit is already 22 hours, as reported by the Wall Street Journal. While the need to scale up is clear and pressing, several factors are creating an active transition into the impending age of teleconsultations.

There is a strong impetus from governments to standardize the use of telehealth tools, such as Centers for Medicare & Medicaid Services (CMS) adding 80 services to be fulfilled via telehealth and Swedish telehealth provider LIVI launching the first UK national guidelines for NHS general practitioners. Likewise, the private sector -- Teladoc for instance -- has moved to expand telehealth capabilities into robotics and virtual assistants that will support healthcare workers. Despite the catalyst being temporary, we are confident that telehealth will become the new normal. Aggressive onboarding of doctors, rapid scale up by vendors like Amwell and Zipnosis, and global evolution of reimbursement and regulatory models will ensure that telehealth becomes the new standard of care for mental health, chronic conditions and dermatology segments.

About the authors

Reenita Das is a healthcare futurist and strategist, passionate about changing the healthcare industry. She recently was voted one of the top 100 women in Femtech and Healthtech. She has lived and worked in over 10 countries in the world, focusing on healthcare issues and working with the public and private sector to implement growth change strategies. Das currently serves as transformational health partner and senior vice president and is the first woman partner at Frost & Sullivan. 

Khushbu Jain, a biodesign and innovation fellow, has over nine years of experience in the healthcare industry in the areas of market research, commercial due diligence and asset scouting for portfolio optimization. Khushbu currently serves as an industry analyst with Frost & Sullivan's Transformational Health vertical. In her current role, her work spans cross-sections of pharmaceutical value chain including specific therapy areas, novel biological products, and pharmaceutical manufacturing.